![](/img/cover-not-exists.png)
European Medicines Agency review of ixazomib (Ninlaro) for the treatment of adult patients with multiple myeloma who have received at least one prior therapy
Tzogani, Kyriaki, Florez, Beatriz, Markey, Greg, Caleno, Mariapaola, Olimpieri, Odoardo Maria, Melchiorri, Daniela, Hovgaard, Doris Johanna, Sarac, Sinan Bardakci, Penttilä, Karri, Lapveteläinen, TuVolume:
4
Journal:
ESMO Open
DOI:
10.1136/esmoopen-2019-000570
Date:
September, 2019
File:
PDF, 650 KB
2019